Forian Inc. (NASDAQ: FORA) announced the sale of its cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., effective February 10, 2023, for a total purchase price of $30
KemPharm (NASDAQ:KMPH) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $0.22 by 18.18 percent. This is a 1700 percent increase over earnings of $0.01 per share from the same